X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (64) 64
female (50) 50
oncology (47) 47
index medicus (39) 39
middle aged (39) 39
adult (34) 34
male (34) 34
aged (33) 33
chemotherapy (16) 16
prognosis (16) 16
breast cancer (14) 14
cancer (14) 14
aged, 80 and over (13) 13
breast neoplasms - drug therapy (12) 12
survival (12) 12
treatment outcome (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
care and treatment (11) 11
clinical trials (11) 11
respiratory system (11) 11
survival analysis (11) 11
follow-up studies (10) 10
immunohistochemistry (10) 10
research (10) 10
breast neoplasms - pathology (9) 9
disease-free survival (9) 9
health aspects (9) 9
chemotherapy, adjuvant (8) 8
drug therapy (8) 8
medicine (8) 8
risk factors (8) 8
aids (7) 7
antineoplastic agents - therapeutic use (7) 7
hospitals (7) 7
neoplasm staging (7) 7
prospective studies (7) 7
research article (7) 7
retrospective studies (7) 7
survival rate (7) 7
therapy (7) 7
time factors (7) 7
breast neoplasms - metabolism (6) 6
cohort studies (6) 6
combined modality therapy (6) 6
disease (6) 6
nsclc (6) 6
patient outcomes (6) 6
risk (6) 6
trastuzumab (6) 6
adjuvant chemotherapy (5) 5
adjuvant treatment (5) 5
adolescent (5) 5
analysis (5) 5
anthracyclines (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
carboplatin (5) 5
cardiac & cardiovascular systems (5) 5
cyclophosphamide (5) 5
dosage and administration (5) 5
drug administration schedule (5) 5
epirubicin - administration & dosage (5) 5
interferon (5) 5
paclitaxel - administration & dosage (5) 5
phase-ii (5) 5
prevalence (5) 5
proportional hazards models (5) 5
radiation-therapy (5) 5
radiotherapy (5) 5
randomized controlled trials as topic (5) 5
studies (5) 5
young adult (5) 5
1506 (4) 4
cancer research (4) 4
carcinoma (4) 4
case-control studies (4) 4
cell lung-cancer (4) 4
cisplatin (4) 4
diagnosis (4) 4
docetaxel (4) 4
gene amplification (4) 4
gene expression (4) 4
genetic aspects (4) 4
greece (4) 4
greece - epidemiology (4) 4
immunotherapy (4) 4
incidence (4) 4
logistic models (4) 4
lung cancer, non-small cell (4) 4
lung neoplasms - pathology (4) 4
lung neoplasms - surgery (4) 4
lung-cancer (4) 4
medical research (4) 4
melanoma - drug therapy (4) 4
models, statistical (4) 4
open-label (4) 4
paclitaxel (4) 4
predictive value of tests (4) 4
proteins (4) 4
receptor, erbb-2 - metabolism (4) 4
recombinant proteins (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 3, pp. 236 - 244
Journal Article
Journal Article
Journal Article
Breast Care, ISSN 1661-3791, 10/2019, pp. 1 - 9
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2009, Volume 27, Issue 18, pp. 2962 - 2969
Purpose To determine whether (1) immunohistochemical (IHC) HER2 status (ie, 2+ or 3+), (2) degree of fluorescence in situ hybridization (FISH) amplification... 
HER-2/NEU | ONCOGENE | GENE | ONCOLOGY | HER2-POSITIVE BREAST-CANCER | Original Reports | To14 | To5 | Bc8
Journal Article
Lancet Respiratory Medicine, The, ISSN 2213-2600, 2017, Volume 5, Issue 5, pp. 435 - 444
Journal Article
Journal of Epidemiology and Community Health, ISSN 0143-005X, 10/2016, Volume 70, Issue 10, pp. 950 - 953
Any study exploring specific research questions requires to test well-defined hypotheses that efficiently translate these questions into measurable quantities.... 
RANDOMISED TRIALS | TRIALS | TESTS | BIOSTATISTICS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | MYOCARDIAL-INFARCTION | Cohort studies | Research Design in Epidemiology | Investigació operativa | Matemàtiques i estadística | Classificació AMS | 90 Operations research, mathematical programming | Àrees temàtiques de la UPC
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 12/2019, Volume 17, Issue 1, pp. 1 - 10
Abstract Background Most ovarian cancer patients are diagnosed at a late stage with 85% of them relapsing after surgery and standard chemotherapy; for this... 
Neoepitope | Cyclophosphamide | Dendritic cell vaccine | Cancer immunotherapy | Neoantigen | Ovarian cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2012, Volume 7, Issue 6, p. e37946
Background: The aim of the present study was to investigate the efficacy of adjuvant dose-dense sequential chemotherapy with epirubicin, paclitaxel, and CMF in... 
PHASE-III TRIAL | COOPERATIVE ONCOLOGY GROUP | NEOADJUVANT CHEMOTHERAPY | MULTIDISCIPLINARY SCIENCES | PROTEIN EXPRESSION | TISSUE MICROARRAYS | BRAIN METASTASES | RISK | DENSE SEQUENTIAL CHEMOTHERAPY | PROGNOSTIC VALUE | DOCETAXEL | Immunohistochemistry | Receptors, Estrogen - metabolism | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Methotrexate - therapeutic use | Breast Neoplasms - drug therapy | Paclitaxel - therapeutic use | Cyclophosphamide - therapeutic use | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Young Adult | Disease-Free Survival | Fluorouracil - therapeutic use | Receptor, Epidermal Growth Factor - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Epirubicin - therapeutic use | Keratin-5 - metabolism | Adult | Female | Aged | Anthracyclines - therapeutic use | Medical research | Anthracyclines | Estrogen | Adjuvant treatment | Breast cancer | Metastasis | Keratin | Paclitaxel | Medicine, Experimental | Rankings | Progesterone | Health aspects | Cancer | Enrichment | Brain | Cytokeratin | Laboratories | Liver | Estrogens | Clinical trials | Estrogen receptors | Oncology | Nervous system | Paraffin | Cancer therapies | Subgroups | Metastases | Proteins | Cell growth | Mastectomy | Epirubicin | Drug dosages | Risk groups | Epidermal growth factor receptors | Health risks | Patients | Survival | ErbB-2 protein | Medicine | Studies | Pathology | Chemotherapy | Brain research | Hospitals | Anthracycline | Collaboration | Medical prognosis | Biomarkers | Trastuzumab | Tumors
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, p. e99131
Journal Article